Hsbc Bk. 20 (89VZ) News

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Goldman Sachs 45th Annual Global Healthcare...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

AbCellera Reports Q1 2024 Business Results

AbCellera (Nasdaq: ABCL) today announced financial results for the first quarter of 2024. All financial information in this press release is...

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies

AbCellera (Nasdaq: ABCL), Viking Global Investors (“Viking”), and ArrowMark Partners (“ArrowMark”) announced today that they have entered into a...

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024

Data show how AbCellera is expanding the reach of T-cell engagers with: CD3-binding antibodies that consistently generate T-cell engagers with...

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024

AbCellera (Nasdaq: ABCL) will announce its first quarter 2024 financial results on Tuesday, May 7, 2024, and hold an earnings conference call at...

AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024

AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Bloom Burton Healthcare Conference on Tuesday...

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions

AbCellera (Nasdaq: ABCL) and Biogen Inc. (Nasdaq: BIIB) have entered into a strategic collaboration to discover antibodies for a novel target...

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024

AbCellera (Nasdaq: ABCL) today announced that its scientists will present four posters with data from its T-cell engager programs and platform at...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report